Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hangzhou Innoforce and Hibiscus Join to Advance Mayo Clinic’s Cell and Gene Therapies

publication date: Sep 1, 2022

The Mayo Clinic, Hibiscus BioVentures and Hangzhou Innoforce launched Mayflower BioVentures, a cell and gene therapy accelerator that will form companies to develop novel Mayo Clinic technologies through preclinical and early feasibility studies. Although Mayo is a hospital, it has generated a portfolio of next-generation immune system modulators and multiple novel therapeutics in cell and gene therapy. Its Center for Regenerative Biotherapeutics works to advance regenerative technologies from discovery into early phase clinical trials, including collaborations with companies like Hibiscus. Innoforce offers CDMO services to cell and gene therapy companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here